Alejandro Galindo - Feb 28, 2022 Form 4/A - Amendment Insider Report for MANNKIND CORP (MNKD)

Role
EVP Endocrine Business Unit
Signature
/s/ Alejandro Galindo
Stock symbol
MNKD
Transactions as of
Feb 28, 2022
Transactions value $
$99,999
Form type
4/A - Amendment
Date filed
8/24/2022, 09:00 PM
Date Of Original Report
Feb 28, 2022
Previous filing
Feb 9, 2022
Next filing
May 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNKD Common Stock,$.01 par value Award $100K +36.9K +6.84% $2.71 577K Feb 28, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being amended to correct the transaction code. The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective February 28, 2022. The purchase was approved by the Company's Board of Directors.